ScoreWhy is Northeast Pharmaceutical Group Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -1.75% and Operating profit at 10.48% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 5.42% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -1.75% and Operating profit at 10.48% over the last 5 years
3
The company declared negative results in Mar'25 after flat results in Dec'24
- NET SALES(HY) At CNY 3,275.09 MM has Grown at -12.48%
- INTEREST COVERAGE RATIO(Q) Lowest at 352.21
- RAW MATERIAL COST(Y) Grown by 8.29% (YoY)
4
With ROE of 7.15%, it has a fair valuation with a 1.43 Price to Book Value
- Over the past year, while the stock has generated a return of -7.33%, its profits have fallen by -4.4%
- At the current price, the company has a high dividend yield of 1.9
5
Below par performance in long term as well as near term
- Along with generating -7.33% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Northeast Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Northeast Pharmaceutical Group Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Northeast Pharmaceutical Group Co., Ltd.
1.97%
1.17
31.48%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.75%
EBIT Growth (5y)
10.48%
EBIT to Interest (avg)
3.57
Debt to EBITDA (avg)
2.66
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.75
Tax Ratio
26.62%
Dividend Payout Ratio
34.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.23%
ROE (avg)
5.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.43
EV to EBIT
20.79
EV to EBITDA
8.61
EV to Capital Employed
1.37
EV to Sales
1.17
PEG Ratio
NA
Dividend Yield
1.86%
ROCE (Latest)
6.61%
ROE (Latest)
7.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-17What is not working for the Company
NET SALES(HY)
At CNY 3,275.09 MM has Grown at -12.48%
INTEREST COVERAGE RATIO(Q)
Lowest at 352.21
RAW MATERIAL COST(Y)
Grown by 8.29% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.49%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.49%
OPERATING PROFIT(Q)
Lowest at CNY 41.28 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 2.14 %
PRE-TAX PROFIT(Q)
Lowest at CNY 66.08 MM
NET PROFIT(Q)
Lowest at CNY 36.32 MM
EPS(Q)
Lowest at CNY 0.03
Here's what is not working for Northeast Pharmaceutical Group Co., Ltd.
Net Profit
At CNY 36.32 MM has Fallen at -64.55%
over average net sales of the previous four periods of CNY 102.46 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest Coverage Ratio
Lowest at 352.21
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Pre-Tax Profit
At CNY 66.08 MM has Fallen at -55.5%
over average net sales of the previous four periods of CNY 148.48 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Sales
At CNY 3,275.09 MM has Grown at -12.48%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 41.28 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 2.14 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 66.08 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 36.32 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.03
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Lowest at 3.49%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 2.49%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 8.29% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.55 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
